Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled Trial
Clinical trial NCT03991013 · COMPLETED
Trial details
- NCT number
- NCT03991013
- Sponsor
- University of Cape Town
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-08
- Primary completion
- 2022-04-26
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.